The central nervous system environment controls effector CD4(+) T cell cytokine profile in experimental allergic encephalomyelitis

被引:87
|
作者
Krakowski, ML [1 ]
Owens, T [1 ]
机构
[1] MCGILL UNIV,MONTREAL NEUROL INST,DEPT NEUROL & NEUROSURG,MONTREAL,PQ H3A 2B4,CANADA
关键词
experimental allergic encephalomyelitis; Th1/Th2; monocyte/macrophage; T lymphocyte; brain;
D O I
10.1002/eji.1830271115
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In experimental allergic encephalomyelitis (EAE), CD4(+) T cells infiltrate the central nervous system (CNS). We derived CD4(+) T cell lines from SJL/J mice that were specific for encephalitogenic myelin basic protein (MBP) peptides and produced both Th1 and Th2 cytokines. These lines transferred EAE to naive mice. Peptide-specific cells re-isolated from the CNS only produced Th1 cytokines, whereas T cells in the lymph nodes produced both Th1 and Th2 cytokines. Mononuclear cells isolated from the CNS, the majority of which were microglia, presented antigen to and stimulated MBP-specific T cell lines in vitro. Although CNS antigen-presenting cells (APC) supported increased production of interferon (IFN)-gamma mRNA by these T cells, there was no increase in the interleukin (IL)-4 signal, whereas splenic APC induced increases in both IFN-gamma and IL-4. mRNA for IL-12 (p40 subunit) was up-regulated in both infiltrating macrophages and resident microglia from mice with EAE. We have thus shown that a Th1 cytokine bias within the CNS can be induced by CNS APC, and that IL-12 is up-regulated in microglial cells within the CNS of mice with EAE. Microglia may therefore control Th1 cytokine responses within the CNS.
引用
收藏
页码:2840 / 2847
页数:8
相关论文
共 50 条
  • [1] THE CNS ENVIRONMENT CONTROLS EFFECTOR CD4+ T-CELL CYTOKINE PROFILE IN EAE
    KRAKOWSKI, M
    OWENS, T
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 146 - 146
  • [2] CD4+ T cell expressed CD80 regulates central nervous system effector function and survival during experimental autoimmune encephalomyelitis
    Podojil, Joseph R.
    Kohm, Adam P.
    Miller, Stephen D.
    JOURNAL OF IMMUNOLOGY, 2006, 177 (05): : 2948 - 2958
  • [3] Gemcitabine directly inhibits effector CD4 T cell activation and prevents experimental autoimmune encephalomyelitis
    Glenn, Justin D.
    Xue, Patrick
    Whartenby, Katharine A.
    JOURNAL OF NEUROIMMUNOLOGY, 2018, 316 : 7 - 16
  • [4] Eomes controls central nervous system inflammation by increasing survival of effector CD4 T cells through the regulation of mitochondrial metabolism
    Joulia, Emeline
    Michieletto, Michael F.
    Agesta, Arantxa
    Peillex, Cindy
    Le Dorze, Anne Louise
    Girault, Virginie
    Lebeurrier, Manuel
    Walzer, Thierry
    Sarry, Jean Emmanuel
    Szelechowski, Marion
    Dejean, Anne S.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 83 - 83
  • [5] Degenerate antigen recognition by CD4(+) effector T cells in experimental autoimmune encephalomyelitis
    McRae, BL
    Karandikar, NJ
    Miller, SD
    JOURNAL OF NEUROIMMUNOLOGY, 1997, 75 (1-2) : 156 - 162
  • [6] Permanent effector phenotype of neuroantigen-specific T cells acquired in the central nervous system during experimental allergic encephalomyelitis
    Hofstetter, HH
    Toyka, KV
    Gold, R
    NEUROSCIENCE LETTERS, 2006, 391 (03) : 127 - 130
  • [7] CD24 is a novel checkpoint that controls expansion of autoreactive T cell in the central nervous system during experimental autoimmune encephalomyelitis
    Bai, XF
    Li, O
    Zhou, QM
    Zhang, HM
    Zheng, P
    Liu, Y
    FASEB JOURNAL, 2004, 18 (05): : A1176 - A1176
  • [9] GLYCINE IN THE CENTRAL NERVOUS-SYSTEM IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
    TURECKY, L
    LISKA, B
    PECHAN, I
    JOURNAL OF NEUROCHEMISTRY, 1980, 35 (03) : 735 - 738